Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2023 May 2;17:11782234231167655. doi: 10.1177/11782234231167655

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2023

This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).

PMC Copyright notice

Figure 2. — DRFS stratified according to clinicopathological factors and TP53 signature. (A) DRFS stratified according to pathological response in all patients. (B) DRFS stratified according to the TP53 signature in patients with RD. (C) DRFS stratified according to nodal status in patients with RD. (D) DRFS stratified according to the TP53 signature in node-negative group of patients with RD. (E) DRFS stratified according to the TP53 signature in node-positive group of patients with RD. DRFS indicates distant recurrence-free survival; LN, lymph node; pCR, pathological complete response; RD, residual disease; TP53 mt sig, TP53 mutant signature; TP53 wt sig, TP53 wild-type signature.

*P < .05; **P < .01; ***P < .001.